These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31206803)

  • 41. The [PSI+] prion of yeast: a problem of inheritance.
    Tuite MF; Cox BS
    Methods; 2006 May; 39(1):9-22. PubMed ID: 16757178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The [PSI+] prion exists as a dynamic cloud of variants.
    Bateman DA; Wickner RB
    PLoS Genet; 2013; 9(1):e1003257. PubMed ID: 23382698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased [PSI+] appearance by fusion of Rnq1 with the prion domain of Sup35 in Saccharomyces cerevisiae.
    Choe YJ; Ryu Y; Kim HJ; Seok YJ
    Eukaryot Cell; 2009 Jul; 8(7):968-76. PubMed ID: 19411620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Sup35 domains required for maintenance of weak, strong or undifferentiated yeast [PSI+] prions.
    Bradley ME; Liebman SW
    Mol Microbiol; 2004 Mar; 51(6):1649-59. PubMed ID: 15009892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disrupting the cortical actin cytoskeleton points to two distinct mechanisms of yeast [PSI+] prion formation.
    Speldewinde SH; Doronina VA; Tuite MF; Grant CM
    PLoS Genet; 2017 Apr; 13(4):e1006708. PubMed ID: 28369054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In Sup35p filaments (the [PSI+] prion), the globular C-terminal domains are widely offset from the amyloid fibril backbone.
    Baxa U; Keller PW; Cheng N; Wall JS; Steven AC
    Mol Microbiol; 2011 Jan; 79(2):523-32. PubMed ID: 21219467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variant-specific [PSI+] infection is transmitted by Sup35 polymers within [PSI+] aggregates with heterogeneous protein composition.
    Bagriantsev SN; Gracheva EO; Richmond JE; Liebman SW
    Mol Biol Cell; 2008 Jun; 19(6):2433-43. PubMed ID: 18353968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro analysis of SpUre2p, a prion-related protein, exemplifies the relationship between amyloid and prion.
    Immel F; Jiang Y; Wang YQ; Marchal C; Maillet L; Perrett S; Cullin C
    J Biol Chem; 2007 Mar; 282(11):7912-20. PubMed ID: 17234629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prion amyloid structure explains templating: how proteins can be genes.
    Wickner RB; Shewmaker F; Edskes H; Kryndushkin D; Nemecek J; McGlinchey R; Bateman D; Winchester CL
    FEMS Yeast Res; 2010 Dec; 10(8):980-91. PubMed ID: 20726897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Normal levels of ribosome-associated chaperones cure two groups of [PSI+] prion variants.
    Son M; Wickner RB
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26298-26306. PubMed ID: 33020283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amyloid formation of a yeast prion determinant.
    Scheibel T
    J Mol Neurosci; 2004; 23(1-2):13-22. PubMed ID: 15126688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analyzing the birth and propagation of two distinct prions, [PSI+] and [Het-s](y), in yeast.
    Mathur V; Taneja V; Sun Y; Liebman SW
    Mol Biol Cell; 2010 May; 21(9):1449-61. PubMed ID: 20219972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxidative stress conditions increase the frequency of de novo formation of the yeast [PSI+] prion.
    Doronina VA; Staniforth GL; Speldewinde SH; Tuite MF; Grant CM
    Mol Microbiol; 2015 Apr; 96(1):163-74. PubMed ID: 25601439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast.
    Ness F; Ferreira P; Cox BS; Tuite MF
    Mol Cell Biol; 2002 Aug; 22(15):5593-605. PubMed ID: 12101251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae.
    Derkatch IL; Bradley ME; Zhou P; Chernoff YO; Liebman SW
    Genetics; 1997 Oct; 147(2):507-19. PubMed ID: 9335589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for the prion hypothesis: induction of the yeast [PSI+] factor by in vitro- converted Sup35 protein.
    Sparrer HE; Santoso A; Szoka FC; Weissman JS
    Science; 2000 Jul; 289(5479):595-9. PubMed ID: 10915616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction between yeast Sup45p (eRF1) and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation.
    Paushkin SV; Kushnirov VV; Smirnov VN; Ter-Avanesyan MD
    Mol Cell Biol; 1997 May; 17(5):2798-805. PubMed ID: 9111351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of divalent copper, manganese and zinc ions on fibril nucleation and elongation of the amyloid-like yeast prion determinant Sup35p-NM.
    Suhre MH; Hess S; Golser AV; Scheibel T
    J Inorg Biochem; 2009 Dec; 103(12):1711-20. PubMed ID: 19853305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro propagation of the prion-like state of yeast Sup35 protein.
    Paushkin SV; Kushnirov VV; Smirnov VN; Ter-Avanesyan MD
    Science; 1997 Jul; 277(5324):381-3. PubMed ID: 9219697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prion protein/protein interactions: fusion with yeast Sup35p-NM modulates cytosolic PrP aggregation in mammalian cells.
    Krammer C; Suhre MH; Kremmer E; Diemer C; Hess S; Schätzl HM; Scheibel T; Vorberg I
    FASEB J; 2008 Mar; 22(3):762-73. PubMed ID: 17928365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.